Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and teenagers between 2 and 17 years old
- People who have been diagnosed with acute lymphoblastic leukemia (a type of blood cancer) confirmed through detailed bone marrow and laboratory testing
- People who are planning to receive their first course of chemotherapy treatment to bring the leukemia into remission, following a recognised childhood leukemia treatment guideline
- People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard scoring system (confirm with trial site)
- People who are expected to live for more than 3 months
- People (or their parent or guardian) who are able to read, understand, and fill in a diary as part of the study
Who may not be able to join:
- People who have a known allergy to the medication dolasetron mesylate or any of its ingredients
- People who have a specific heart rhythm abnormality where a measurement called the QTc interval is 460 milliseconds or longer (confirm with trial site)
- People where the research team has identified another reason that joining the trial would not be appropriate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: （+86）13855189560
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Response (CR) rate during 0-120 hour after chemotherapy (global phase)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.